CVS vs PGNY

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 01, 2026

CVS

58.4
AI Score
VS
CVS Wins

PGNY

46.3
AI Score

Investment Advisor Scores

CVS

58score
Recommendation
HOLD

PGNY

46score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CVS PGNY Winner
Forward P/E 10.6724 11.8483 CVS
PEG Ratio 0.2113 0 Tie
Revenue Growth 7.1% 5.3% CVS
Earnings Growth 188.8% 78.9% CVS
Tradestie Score 58.4/100 46.3/100 CVS
Profit Margin 1.2% 6.0% PGNY
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

CVS 1M: -11.1% · 3M: -15.3% PGNY 1M: -4.0% · 3M: -18.4%

Current Technical Phase

CVS

Markdown
Sell / avoid

Price below a falling SMA50 (slope -6.0%), weak momentum, RSI 37

RSI (14): 36.8 · Price: $86.46

PGNY

Markdown
Sell / avoid

Price below a falling SMA50 (slope -6.0%), weak momentum, RSI 40

RSI (14): 40.1 · Price: $25.23

Fundamentals Snapshot

Metric CVS PGNY
Market Cap — —
Forward P/E 10.1 10.9
Trailing P/E 22.6 27.3
Revenue (TTM) — —
Revenue Growth 0.1% 0.1%
Gross Margin 0.1% 0.2%
Operating Margin 0.0% 0.1%
EPS 3.77 0.91
Dividend Yield 0.03% —

Frequently Asked Questions

Based on our detailed analysis, CVS is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.